Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SenoRx' breast brachytherapy tool:

This article was originally published in Clinica

Executive Summary

The US FDA has given SenoRx 510(k) clearance to market its Multi-Lumen Radiation Balloon Applicator for providing brachytherapy to the surgical margins following lumpectomy for breast cancer. The device uses vacuum to remove excess fluid and to adhere closely to often irregularly shaped lumpectomy cavities in order to deliver precise radiation dosing through multiple seed lumens. "Certain patients who are presently candidates for balloon therapy are currently excluded because of the location of the lesion relative to their breast size," claimed Lloyd Malchow, the Aliso Viejo, California firm's president and CEO. "Our multi-lumen approach offers a solution to this problem."

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048477

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel